San Diego, CA, United States · ISCB
Stem cell–based models are transforming disease understanding and accelerating drug discovery. This three-day symposium brings together global leaders from academia, industry, and the clinic to explore these transformative platforms. Sessions will feature advances in organoid systems that integrate multiple cell types, innovations in bioengineering, patient-derived tumor models, and AI-driven analytical approaches. Applications span cancer biology, therapeutic screening, and even disease modeling in low-Earth orbit. The program will highlight the field’s maturation, from academic discovery tools to industry-standard screening systems and approved therapies, while addressing the remaining challenges to broad adoption of stem cell–derived disease models in drug development.